Osteoporosis New Zealand has appointed its new Executive Director, Christine Gill.  Reporting to Chairman, Paul Mitchell, Christine will be responsible for supporting the board in achieving their strategic direction and contribute toward building the reputation and profile of ONZ nationally and internationally. Better bones and fewer fractures

After graduating from Massey University with a BSC (Biochem), Christine started her career as a member of the Connective Tissue Research Group, Department of Surgery, at Auckland University’s School of Medicine.

Following some years gathering experience in the infant nutritional and pharmaceutical sectors, Christine held the position of General Manager of Horleys where she and her team developed a number of nutritional products targeting specific demographics within the market.

For the past decade Christine has co-founded Flavorjen – a company providing innovation through the incorporation of specialised ingredients into the food and beverage manufacturing sector.

Christine has a passion for sport that she shares with her husband and two children. You may see her out running the streets of Auckland, at the gym or Mountain biking through the forests.

With over 25 years’ experience in the medical research, pharmaceutical and nutritional sectors, Christine is excited and motivated to be joining the Osteoporosis New Zealand team.